학술논문
Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.
Document Type
journal article
Author
Source
American Journal of Nephrology; Oct2018, Vol. 48 Issue 3, p172-180, 9p, 3 Diagrams, 1 Chart
Subject
Language
ISSN
02508095
Abstract
Copyright of American Journal of Nephrology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)